-
HyperFluor™ 594 Antibody: From Causality to Imaging
2026-08-18
Learn how the HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody converts causal atherosclerosis findings into rigorous spatial, cellular, and quantitative assays. This guide emphasizes assay logic, controls, multiplex design, and interpretation across immunofluorescence, histology, flow cytometry, and ELISA.
-
N-MYC–eIF4G1 Signaling in inv(16) AML
2026-08-18
The reference study identifies an N-MYC–eIF4G1 survival axis that maintains acute myeloid leukemia with inv(16), linking a previously uncharacterized MYCN enhancer to leukemic cell fitness. Its combination of transcriptomic, chromatin, genetic, primary-cell, and patient-derived xenograft analyses provides a framework for studying transcriptional dependencies in genetically defined AML.
-
N-MYC/eIF4G1 Survival Axis in inv(16) AML
2026-08-17
Peramangalam et al. identify a previously unrecognized MYCN enhancer and establish an N-MYC/eIF4G1 pathway that supports survival in inv(16) acute myeloid leukemia. The study connects CBFβ-SMMHC-dependent transcriptional dysregulation to translational control and provides a mechanistic framework for targeted acute myeloid leukemia research.
-
MK-0812 as a CCR2 Lens on Gut–Liver MASH
2026-08-17
MK-0812 enables precise dissection of CCR2-dependent monocyte recruitment within TM6SF2-driven gut–liver inflammation. This article translates recent MASH findings into assay logic that separates epithelial, lipid, microbial, and immune mechanisms.
-
Hydroxychloroquine Sulfate Workflow Guide
2026-08-16
Hydroxychloroquine Sulfate (SKU B4874) provides an aqueous-compatible tool for examining autophagy pathway modulation and TLR7/9-dependent immune signaling in autoimmune disease research. It is appropriate for short-term water-based workflows, but should not be selected for protocols requiring DMSO or ethanol solubility or long-term storage of prepared solutions.
-
FITC Goat Anti-Mouse IgG (H+L) Antibody
2026-08-15
A scenario-based guide to using the FITC Goat Anti-Mouse IgG (H+L) Antibody, SKU K1201, for reproducible immunofluorescence and flow cytometry readouts in viability, proliferation, and cytotoxicity workflows. It connects assay controls, storage, signal interpretation, and practical reagent-selection criteria to current cell-proliferation evidence.
-
AMG 487: CXCR3 Antagonist Workflow Guide
2026-08-14
AMG 487 provides a selective way to dissect CXCR3 signaling across chemotaxis, calcium flux, macrophage polarization, and inflammatory models. This guide translates its reported potency into practical assay design while highlighting context-dependent biology revealed by the LAMP1–CXCL10–CXCR3 axis.
-
SB 431542: Practical ALK5 Inhibitor Workflows
2026-08-14
SB 431542 is a selective ALK5 inhibitor for separating TGF-β-driven signaling from downstream effects on proliferation, motility, stemness, and immune regulation. This guide translates the reference study into dose-response, Smad2 readouts, CD44 assays, and troubleshooting strategies for reproducible cell-based research.
-
AL-8810: Prostaglandin F2α Antagonist Workflows
2026-08-13
AL-8810 enables receptor-level dissection of PGF2α signaling in endometrial, vascular, ocular, and smooth-muscle models. This workflow guide connects competitive FP receptor antagonism with practical readouts such as ERK1/2 activation, vascular permeability, and MMP-2 secretion.
-
Palonosetron and CINV Prevention: Evidence and Mechanism
2026-08-13
Ruhlmann and Herrstedt review palonosetron hydrochloride as a long-acting 5-HT3 receptor antagonist whose high affinity, allosteric binding, and positive cooperativity may help extend antiemetic activity beyond the acute chemotherapy period. The paper’s practical contribution is a critical comparison of pharmacology, preclinical evidence, clinical trials, and tolerability rather than a simple claim that newer receptor biology automatically produces superior outcomes.
-
Angiotensin II, Cx43, and M1 Macrophage Polarization
2026-08-12
The reference study identifies a connexin 43/NF-κB p65 signaling axis through which Angiotensin II promotes inflammatory M1-like polarization in RAW264.7 macrophages. Its combined inhibitor and multi-assay design links Angiotensin II exposure to cytokine production and macrophage phenotype, while also defining important limits for translation to primary cells and cardiovascular disease models.
-
TAK-242: Practical TLR4 Inhibition Workflows
2026-08-12
TAK-242 (Resatorvid) gives researchers a selective way to interrogate TLR4-driven inflammation, from LPS-stimulated macrophages to microglial responses in heatstroke models. This guide translates the latest cerebral-injury findings into practical assay design, protocol starting points, and troubleshooting strategies.
-
HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody
2026-08-11
Build high-contrast ICC/IF, plaque IHC, flow cytometry, and ELISA workflows around a spectrally defined goat anti-rabbit IgG secondary antibody. The workflow connects ISG20-focused atherosclerosis research with practical controls, multiplexing decisions, and troubleshooting strategies.
-
Maternal IL-17A and Neonatal GBS Risk
2026-08-11
A prospective mother–newborn study in Morocco links reduced maternal IL-17A, IL-1β, and IL-4 responses with invasive Group B Streptococcus disease in newborns. The findings position circulating maternal IL-17A as a promising risk-stratification biomarker and show how ex vivo pathogen-recognition receptor stimulation can complement clinical cytokine profiling.
-
CHIR-99021 (CT99021) in Stem Cell Research
2026-08-10
CHIR-99021, also called CT99021, is a selective glycogen synthase kinase-3 inhibitor used to modulate Wnt/β-catenin signaling in stem-cell workflows. Its reported GSK-3α/β potency and application in vascularized pancreatic progenitor differentiation make it useful for controlled lineage specification, although concentration, timing, and cell context determine outcomes.